Nea Management Company, LLC Black Diamond Therapeutics, Inc. Transaction History
Nea Management Company, LLC
- $1.31 Billion
- Q3 2024
A detailed history of Nea Management Company, LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 4,448,757 shares of BDTX stock, worth $9.74 Million. This represents 1.48% of its overall portfolio holdings.
Number of Shares
4,448,757
Previous 4,448,757
-0.0%
Holding current value
$9.74 Million
Previous $20.7 Million
6.65%
% of portfolio
1.48%
Previous 1.96%
Shares
3 transactions
Others Institutions Holding BDTX
# of Institutions
117Shares Held
48.8MCall Options Held
1.84MPut Options Held
1.93M-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$23.5 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$18.7 Million0.62% of portfolio
-
Vestal Point Capital, LP New York, NY5.03MShares$11 Million1.66% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$7.05 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$5.08 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $79.6M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...